Catheter Precision (VTAK) Proxy Filing summary

Executive summary

• Annual meeting scheduled for July 25, 2025, to be held virtually, with registration required by July 24, 2025.

• Proxy materials, including the notice, proxy statement, and annual report, are available online and by request.

• Stockholders can vote online, by mail, or by telephone, using an 11-digit control number.

Voting matters and shareholder proposals

• Election of one Class I director.

• Approval for issuance of up to 4,285,716 shares upon exercise of Series L Warrants.

• Approval for issuance of up to 8,574,000 shares upon conversion of Series B Convertible Preferred Stock.

• Approval for issuance of up to 257,143 shares upon exercise of 2025 Placement Agent Warrants.

• Approval of a reverse stock split at a ratio between 1-for-5 and 1-for-19, with the final ratio at the board's discretion.

• Ratification of WithumSmith + Brown, PC as independent auditor for fiscal year ending December 31, 2025.

Board of directors and corporate governance

• Board recommends voting FOR all proposals and the director nominee.